# US 2024/0302278 A1 · A cynadide determination system and a method for obtaining gold nanoclusters used in the system

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2024/0302278 A1
- Document ID: US20240302278A1
- Status: Published application
- Kind: A1
- Application number: 18/552,402
- Filed: 2022-03-31
- Published: 2024-09-12
- Earliest claimed: 2021-03-31
- Assignees: Hacettepe Universitesi Rektorluk
- Applicants: Hacettepe Universitesi Rektorluk
- Inventors: Ugur AYDIN; Memed DUMAN
- Web page: https://patentgrep.com/patent/US20240302278A1

## CPC

- G01N 21/6428: {Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes" (in vivo A61B5/00; immunoassay G01N33/53)}
- G01N 33/54373: {involving physiochemical end-point determination, e.g. wave-guides, FETS, gratings}
- B01L 3/502707: {characterised by the manufacture of the container or its components}
- G01N 1/4077: {by other techniques involving separation of suspended solids}
- G01N 21/6456: {Spatial resolved fluorescence measurements; Imaging}
- G01N 33/585: {with a particulate label, e.g. coloured latex}
- G01N 33/94: involving narcotics {or drugs or pharmaceuticals, neurotransmitters or associated receptors}
- B01L 2300/0806: Standardised forms, e.g. compact disc [CD] format
- B01L 2300/0864: comprising only one inlet and multiple receiving wells, e.g. for separation, splitting
- B01L 2400/0409: centrifugal forces
- G01N 2001/4083: {sedimentation}
- G01N 2021/6439: {with indicators, stains, dyes, tags, labels, marks}
- G01N 2800/42: Poisoning, e.g. from bites or stings
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- B01L: CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE

## Abstract

The present invention relates to a system which enables to carry out cyanide determination in biological samples taken from the living beings who are exposed to cyanide gas and/or cyanide components especially released from the industry and/or house fires, and a method of obtaining gold nanoclusters used in the system.

## Claims

### Claim 1

A system (1) which enables to carry out cyanide determination in biological samples taken from the living beings who are exposed to cyanide gas and/or cyanide components released from the industry and/or house fires; characterized in that it comprises:
at least one microfluidic compact disc (CD) (2) which consists of at least one layer having at least one channel and at least one chamber having an area wherein the plasma of a blood sample, which is a biological sample, can be filled to be separated;
at least one centrifuge device (3) whereon the compact disc (2) is placed and which enables the centrifugation process that is required to separate the blood sample in the compact disc (2) into its plasma;
a gold nanocluster (AuNC) (4) which is located in the compact disc (2), has a fluorescent color emitting property, and the fluorescent color of which can fade at different rates according to the cyanide concentration by interacting with the cyanide in the plasma when it is combined with the plasma separated from the cyanide-containing blood sample;
at least one electronic device (5) which is configured to enable to capture image for the purpose of determination of fluorescent colors of the combination of gold nanoclusters (4) and the cyanide-containing plasma under UV light in order to determine the amount of cyanide in the blood plasma under examination; and
at least one application (6) which is executed on the electronic device (5) and configured to determine the amounts of cyanide corresponding to the colors in the images captured by the electronic device (5).

### Claim 2

(canceled)

### Claim 3

(canceled)

### Claim 4 (depends on 1)

A system (1) according to claim 1; characterized by the compact disc (2) which comprises three polymethylmethacrylate (PMMA) layers—namely the top (21), the middle (23) and the bottom (25) one- and double-sided tape layers with adhesive properties—namely, the first adhesive (22) and the second adhesive (24)—to be placed between these layers (21, 23, 25).

### Claim 5

(canceled)

### Claim 6

(canceled)

### Claim 7

(canceled)

### Claim 8 (depends on 4)

A system (1) according to claim 4; characterized by the compact disc (2) which comprises the middle PMMA layer (23) with five different chambers-namely, the filling (231), the separation (232), the pneumatic (233), the plasma collection (234) and the comparison chamber (235).

### Claim 9

(canceled)

### Claim 10 (depends on 8)

A system (1) according to claim 8; characterized by the compact disc (2) which comprises the middle PMMA layer (23) with a second channel (2331) that carries the plasma-passing through the channel from the separation chamber (232) to the pneumatic chamber (233) during the centrifugation process being carried out for the separation process—from the pneumatic chamber (233) to the plasma collection chamber (234).

### Claim 11

(canceled)

### Claim 12 (depends on 8)

A system (1) according to claim 8; characterized by the compact disc (2) which comprises the middle PMMA layer (23) with the filling chamber (231) configured to be the place wherein the sample desired to be analyzed is dripped in order to determine the cyanide content.

### Claim 13 (depends on 8)

A system (1) according to claim 8; characterized by the compact disc (2) which comprises the middle PMMA layer (23) with the middle PMMA layer (23) configured to be the place wherein the sample to be analyzed is sent before the centrifugation process.

### Claim 14 (depends on 8)

A system (1) according to claim 8; characterized by the compact disc (2) which comprises the middle PMMA layer (23) with pneumatic chamber (233) configured to be the place wherein the plasma separated from the blood, that is the biological sample, is collected during the centrifugation process of the sample to be analyzed.

### Claim 15 (depends on 8)

A system (1) according to claim 8; characterized by the compact disc (2) which comprises the middle PMMA layer (23) with the plasma collection chamber (234) configured to be the place wherein the plasmas that are collected in the pneumatic chamber (233) by being separated from the blood by AuNCs are mixed with each other.

### Claim 16 (depends on 8)

A system (1) according to claim 8; characterized by the compact disc (2) which comprises the middle PMMA layer (23) with the plasma collection chamber (234) containing the AuNC solution and an empty volume for the plasma leaving the blood to come in.

### Claim 17

(canceled)

### Claim 18 (depends on 8)

A system (1) according to claim 8; characterized by the compact disc (2) which comprises the middle PMMA layer (23) with the comparison chamber (235) configured to contain a mixture of buffer solution and AuNC solution.

### Claim 19

(canceled)

### Claim 20 (depends on 8)

A system (1) according to claim 8; characterized by the compact disc (2) which comprises the middle PMMA layer (23) with the comparison chamber (235) configured to enable the composition of plasma and AuNC in the plasma collection chamber (234) to be compared with the fluorescent color emitted by AuNCs that do not comprise plasma.

### Claim 21

(canceled)

### Claim 22

(canceled)

### Claim 23 (depends on 8)

A system (1) according to claim 8; characterized by the compact disc (2) which has the bottom PMMA layer (25) comprising holes that allow the blood sample to be filled for cyanide detection, and ventilation holes in order to adjust the required pressure and to prevent the formation of air bubbles during filling.

### Claim 24

(canceled)

### Claim 25

(canceled)

### Claim 26

(canceled)

### Claim 27

(canceled)

### Claim 28

(canceled)

### Claim 29 (depends on 1)

A system (1) according to claim 1; characterized by the electronic device (5) which enables the images of cyanide-containing samples, that are centrifuged in the compact disc (2) and emit different fading colors according to the cyanide concentration by combining with AuNCs, to be captured under UV light.

### Claim 30

(canceled)

### Claim 31 (depends on 1)

A system (1) according to claim 1; characterized by the application (6) which is executed on the electronic device (5) and determines the cyanide concentration in the sample from the color data in the image by ensuring that the images captured by the electronic device (5) are evaluated according to the colors stored in the database within the application (6) and the cyanide reference values corresponding to these colors.

### Claim 32 (depends on 31)

A system (1) according to claim 31; characterized by the application (6) which is the Color Grab application which presents values through the L*a*b* color system for color changes due to the fading mechanisms of AuNCs.

### Claim 33

A method (100) for obtaining gold nanocluster (AuNC) (4) which emits fluorescent color, wherein the fluorescent color fades in accordance with the cyanide concentration when interacting with cyanide, and which is used as the detection mechanism of the gold atoms of the cyanide; characterized in that it comprises the steps of:
adding an aqueous HAuCl4.3H2O solution and bovine serum albumin (BSA) solution into a vessel wherein a mixing process is applied (101);
forming AuNCs by adding NaOH into the solution within the vessel to initiate the formation of AuNCs (102); and
obtaining AuNCs (4) by filtering the solution within the vessel containing the formed AuNCs (103).

### Claim 34 (depends on 33)

A method (100) according to claim 33; characterized in that in the step of adding an aqueous HAuCl4.3H2O solution and bovine serum albumin (BSA) solution into a vessel wherein a mixing process is applied (101) of the inventive method (100); into a glass vessel, washed with aqua regia solution, rinsed with deionized water and dried; 5 ml of 50 mg/ml BSA solution used as stabilizing agent is added into 5 ml of 10 mM aqueous HAuCl4.3H2O solution under vigorous stirring at 30-40° C.

### Claim at position 35

35-43. (canceled)

### Claim 44 (depends on 33)

A method (100) according to claim 33; characterized in that the NaOH, which is used to adjust the pH of the solution during the reaction, causes conformational changes in the secondary structure of BSA and thus enables the Au atoms to be clustered (packaged) in BSA and therefore realizes the formation of AuNC.

### Claim at position 37

45-48. (canceled)

### Claim 49 (depends on 33)

A method (100) according to claim 33; characterized in that in the step of obtaining AuNCs (4) by filtering the solution within the vessel containing the formed AuNCs (103); it is understood that the synthesis is completed when the color of the reaction solution changes from light yellow to brown and the solution is filtered through a filter with 0.2-0.5 m pore size and stored at 4° C. or frozen to obtain pure BSA-AuNCs powder.

### Claim 50 (depends on 33)

A system (1) wherein the AuNCs obtained by following the step of the method (100), which is disclosed in claim 33, is used.
